Showing results (1711-1720 of 1,899) with videos related to
Sort By:
Pageof 190
Immunotherapy|May 17, 2019
B-cell maturation antigen directed monoclonal antibody therapies for multiple myelomaErik Eckhert, Rhonda Hewitt, Michaela LiedtkeImmunotherapy|May 17, 2019
Safety of uSCIT-MPL-4: prevalence and risk factors of systemic reactions in real lifeMarco Caminati, Alessandra Arcolaci, Massimo Guerriero, et al.Immunotherapy|May 17, 2019
Are mimotope vaccines a good alternative to monoclonal antibodies?Mona Pourjafar, Pouria Samadi, Hamed Manoochehri Khoshinani, et al.Immunotherapy|May 29, 2019
Toxicity patterns associated with chemotherapy/immune checkpoint inhibitor combinations: a meta-analysisOmar Abdel-RahmanImmunotherapy|September 24, 2021
Clinical predictors of chimeric antigen receptor T-cell therapy neurotoxicity: a single-center studyCarlen Yuen, Kourosh Rezania, Thomas Kelly, et al.Immunotherapy|February 7, 2022
Subcutaneous immunoglobulin use in immunoglobulin-naive patients with primary immunodeficiency: a systematic reviewColin Anderson-Smits, Michelle Park, Judith Bell, et al.Immunotherapy|October 21, 2021
Body composition and inflammation impact in non-small-cell lung cancer patients treated by first-line immunotherapyCinzia Baldessari, Annarita Pecchi, Raffaella Marcheselli, et al.Immunotherapy|March 21, 2022
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatmentHenrry Diaz Londres, Jorge Jiménez Armada, Aray Hernández Martínez, et al.Immunotherapy|April 4, 2022
PD-1/L1 inhibitors may increase the risk of pericardial disease in non-small-cell lung cancer patients: a meta-analysis and systematic reviewHonglin Li, Deting Han, Lei Zhang, et al.Pageof 190